ArticleScientific reports2024

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients.

Julio Collazos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.